GSK plc’s strong oncology growth, highlighted by Ojjaara sales and an upgraded 2025 outlook, earns a continued 'Buy' rating. Learn more about GSK stock here.
Opinion
Yarnhub on MSNOpinion

How Jet Fighters Faced Off Against Mustangs

Late in the war the Luftwaffe’s revolutionary Messerschmitt Me 262 met the Allies’ pinnacle propeller fighter, the P-51D Mustang, in the skies over Germany. Luftwaffe pilots recalled the encounters as ...
According to the dealer ad, today's Nice Price or No Dice E46 M3 "pulls strong." Let's decide if the price tag means they are trying to pull our collective leg. Like any smart carmaker these days, ...